Literature DB >> 31451980

Hypertension in Premenopausal and Postmenopausal Women.

Yasmin Brahmbhatt1, Maitreyee Gupta2, Seyed Hamrahian2.   

Abstract

PURPOSE OF REVIEW: To examine available clinical data on the differences between premenopausal and postmenopausal women with hypertension (HTN). Clinical conditions related to HTN and reproductive status differ in younger women compared with older women. Due to recent changes in the definition of HTN, the prevalence of HTN has increased significantly in all women. Rising rates of obesity among women of all ages increase the risk for HTN. RECENT
FINDINGS: Among younger women, long-term vascular consequences of preeclampsia, the under-reported prevalence of fibromuscular dysplasia, and widespread use of oral contraceptive pills in women with contraindications confer unique risks for HTN-related cardiovascular risk. For older women, insights on vascular aging and hormonal changes with menopause are shown to be gender-specific causal factors for HTN. Assessment of risk factors unique to premenopausal and postmenopausal women can facilitate the management of HTN and improve long-term outcomes. Further studies in women are needed to accurately stratify women risk based on these risk factors.

Entities:  

Keywords:  Hypertension; Postmenopause; Premenopause; Risk factors; Women

Mesh:

Year:  2019        PMID: 31451980     DOI: 10.1007/s11906-019-0979-y

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  52 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

2.  Hypertension in adults across the age spectrum: current outcomes and control in the community.

Authors:  Donald M Lloyd-Jones; Jane C Evans; Daniel Levy
Journal:  JAMA       Date:  2005-07-27       Impact factor: 56.272

3.  Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trial.

Authors:  Alberto Zanchetti; Stevo Julius; Sverre Kjeldsen; Gordon T McInnes; Tsushung Hua; Michael Weber; John H Laragh; Francis Plat; Edouard Battegay; Cesar Calvo-Vargas; Andrzej Cieśliński; Jean Paul Degaute; Nicolaas J Holwerda; Janna Kobalava; Ole Lederballe Pedersen; Faustinus P Rudyatmoko; Kostas C Siamopoulos; Oyvind Störset
Journal:  J Hypertens       Date:  2006-11       Impact factor: 4.844

4.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Authors:  Jackson T Wright; George Bakris; Tom Greene; Larry Y Agodoa; Lawrence J Appel; Jeanne Charleston; DeAnna Cheek; Janice G Douglas-Baltimore; Jennifer Gassman; Richard Glassock; Lee Hebert; Kenneth Jamerson; Julia Lewis; Robert A Phillips; Robert D Toto; John P Middleton; Stephen G Rostand
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

5.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Authors:  B M Brenner; M E Cooper; D de Zeeuw; W F Keane; W E Mitch; H H Parving; G Remuzzi; S M Snapinn; Z Zhang; S Shahinfar
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

Review 6.  Sex hormones and hypertension.

Authors:  Raghvendra K Dubey; Suzanne Oparil; Bruno Imthurn; Edwin K Jackson
Journal:  Cardiovasc Res       Date:  2002-02-15       Impact factor: 10.787

Review 7.  Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials.

Authors:  Fiona Turnbull; Mark Woodward; Bruce Neal; Federica Barzi; Toshiharu Ninomiya; John Chalmers; Vlado Perkovic; Nicole Li; S MacMahon
Journal:  Eur Heart J       Date:  2008-10-13       Impact factor: 29.983

8.  Mortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sex.

Authors:  Suzanne Oparil; Barry R Davis; William C Cushman; Charles E Ford; Curt D Furberg; Gabriel B Habib; L Julian Haywood; Karen Margolis; Jeffrey L Probstfield; Paul K Whelton; Jackson T Wright
Journal:  Hypertension       Date:  2013-03-25       Impact factor: 10.190

9.  Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.

Authors:  Kenneth Jamerson; Michael A Weber; George L Bakris; Björn Dahlöf; Bertram Pitt; Victor Shi; Allen Hester; Jitendra Gupte; Marjorie Gatlin; Eric J Velazquez
Journal:  N Engl J Med       Date:  2008-12-04       Impact factor: 91.245

10.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

View more
  8 in total

Review 1.  Sex differences in autonomic responses to stress: implications for cardiometabolic physiology.

Authors:  Carley Dearing; Robert J Handa; Brent Myers
Journal:  Am J Physiol Endocrinol Metab       Date:  2022-07-06       Impact factor: 5.900

2.  Clinical practice guideline of the Interamerican Society of Cardiology on primary prevention of cardiovascular disease in women.

Authors:  Mildren A Del-Sueldo; María A Mendonça-Rivera; Martha B Sánchez-Zambrano; Judith Zilberman; Ana G Múnera-Echeverri; María Paniagua; Lourdes Campos-Alcántara; Claudia Almonte; Amalia Paix-Gonzales; Claudia V Anchique-Santos; Claudine J Coronel; Gabriela Castillo; María G Parra-Machuca; Ivanna Duro; Paola Varletta; Patricia Delgado; Verónica I Volberg; Adriana C Puente-Barragán; Adriana Rodríguez; Aida Rotta-Rotta; Anabela Fernández; Ana C Izeta-Gutiérrez; Ana E Ancona-Vadillo; Analía Aquieri; Andrea Corrales; Andrea Simeone; Bibiana Rubilar; Carolina Artucio; Carolina Pimentel-Fernández; Celi Marques-Santos; Clara Saldarriaga; Christian Chávez; Cristina Cáceres; Dahiana Ibarrola; Daniela Barranco; Edison Muñoz-Ortiz; Edith D Ruiz-Gastelum; Eduardo Bianco; Elena Murguía; Enrique Soto; Fabiola Rodríguez-Caballero; Fanny Otiniano-Costa; Giovanna Valentino; Iris B Rodríguez-Cermeño; Ivan R Rivera; Jairo A Gándara-Ricardo; Jesús A Velásquez-Penagos; Judith Torales; Karina Scavenius; Karen Dueñas-Criado; Laura García; Laura Roballo; Lucía R Kazelian; Macarena Coussirat-Liendo; María C Costa-Almeida; Mariana Drever; Mariela Lujambio; Marildes L Castro; Maritza Rodríguez-Sifuentes; Mónica Acevedo; Mónica Giambruno; Mónica Ramírez; Nancy Gómez; Narcisa Gutiérrez-Castillo; Onelia Greatty; Paola Harwicz; Patricia Notaro; Rocío Falcón; Rosario López; Sady Montefilpo; Sara Ramírez-Flores; Silvina Verdugo; Soledad Murguía; Sonia Constantini; Thais C Vieira; Virginia Michelis; César M Serra
Journal:  Arch Cardiol Mex       Date:  2022

3.  Emergent Anthropometric Indices in Differential Prediction of Prehypertension and Hypertension in Mexican Population: Results according to Age and Sex.

Authors:  Oscar Zaragoza-García; Ilse Adriana Gutiérrez-Pérez; Pedro Delgado-Floody; Isela Parra-Rojas; Daniel Jerez-Mayorga; Christian Campos-Jara; Iris Paola Guzmán-Guzmán
Journal:  Int J Hypertens       Date:  2022-07-07       Impact factor: 2.434

4.  Joint effect of 25-hydroxyvitamin D and secondhand smoke exposure on hypertension in non-smoking women of childbearing age: NHANES 2007-2014.

Authors:  Qianqian Shen; Qian Xu; Guoju Li; Lisheng Ren; Zhenhong Zhang; Yangting Zhang; Zhaoyi Zhong; Xiaona Li; Qiuzhen Wang
Journal:  Environ Health       Date:  2021-11-15       Impact factor: 5.984

5.  Effect of free androgen index on blood pressure variability and target organ damage in postmenopausal hypertensive women: findings from a cross-sectional study.

Authors:  Jianshu Chen; Qiongying Wang; Ying Pei; Ningyin Li; Junchen Han; Jing Yu
Journal:  Menopause       Date:  2021-08-23       Impact factor: 3.310

6.  Sex-Specific Trends in the Prevalence of Hypertension and the Number of People With Hypertension: Analysis of the Korea National Health and Nutrition Examination Survey (KNHANES) 1998-2018.

Authors:  Eunsun Seo; Sunjae Jung; Hokyou Lee; Hyeon Chang Kim
Journal:  Korean Circ J       Date:  2022-02-07       Impact factor: 3.101

Review 7.  Hypertension in Women.

Authors:  Tatjana Tasić; Marijana Tadić; Maja Lozić
Journal:  Front Cardiovasc Med       Date:  2022-06-03

8.  mTOR inhibitor improves testosterone-induced myocardial hypertrophy in hypertensive rats.

Authors:  Jianshu Chen; Jing Yu; Ruowen Yuan; Ningyin Li; Caie Li; Xiaofang Zhang
Journal:  J Endocrinol       Date:  2022-01-31       Impact factor: 4.286

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.